Dr
Jamie
Thomson

Partner & Patent Attorney

Edinburgh Office Glasgow Office

Chemistry

Telephone. 44(0) 131 220 7500
Mobile. +44(0) 771 748 3525
Email. [email protected]

Experience

Jamie has over 20 years’ experience in the patent profession, working both in private practise and in-house. He specialises in the field of chemistry, particularly medical devices, pharmaceuticals and performance chemicals.

As well as drafting and prosecuting patent applications and managing global patent portfolios, he handles contentious EPO opposition and appeal proceedings having gained significant experience whilst living and working in Munich. Jamie also provides strategic advice on IP portfolios, and opinions on the infringement and validity of patents.

Qualifications

Patent Attorney

Chartered (UK)
European


BSC

B. Sc. (Hons) Chemistry, First Class, University of St Andrews

PHD

Ph. D. (Chemistry), University of St Andrews

Recognition

MIP Patent Star

View recognition online

IAM Patent 1000

"In Edinburgh, Jamie Thomson manages global patent portfolios in the fields of medical devices, pharmaceuticals and performance chemicals. He is also no stranger to oppositions and appeals at the EPO, having gained abundant experience in the area over two years stationed in Munich."

View recognition online

Publications

IAM Patent 1000 2020

View publication online

MIP IP Stars 2020

View publication online

IAM Patent 1000 2019

View publication online

HGF awarded 'Winner of the Prosecution Firm of the year' UK (Scotland) 2019 at the Managing IP - Global IP awards

View publication online

CSR

Jamie sits on the Law Society of Scotland’s IP sub-committee, which reviews new IP legislation effecting Scotland.

Related News

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details
Event - 10th March 2022

Manufacturing & Supply Chain Conference 2022

HGF Patent Attorney Dr Robert Weinert-Aplin is attending and speaking at the Manufacturing & Supply Chain Conference on 10th March 2022 in Milton Keynes, UK. The Manufacturing & Supply Chain …

Event details

The Microbiome Times: ELIGO v SNIPR: a reflection on IP strategies in a competitive environment

HGF Partner and Patent Attorney Craig Thomson and Patent Director Dr Jennifer Bailey write an article for The Microbiome Times on ELIGO v SNIPR: a reflection on IP strategies in …

Read article

UPC could open its doors in 2022

With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.